2 months ago
GILD
AnalystsHartaj SinghHartaj Singh's Stock Forecasts
AnalystsHartaj Singh
Sectors:
Industries:
Analyst Ranking
Bottom 4%
#4706 out of 4862 analysts
Average Return
-10.46%
Win Rate
42%38 out of 90
Risk vs Reward
Poor
Good
Hartaj Singh's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Moderna IncMRNA | +329.18% | $37.25 | $159.87 | 2020-04-14 - 2021-04-15 | Buy |
Icosavax IncICVX | +177.86% | $5.51 | $15.31 | 2023-04-24 - 2024-02-16 | Buy |
Moderna IncMRNA | +162.71% | $157.48 | $413.72 | 2021-01-31 - 2021-08-06 | Buy |
Astria Therapeutics IncATXS | +124.72% | $4.49 | $10.09 | 2023-11-15 - 2024-11-14 | Buy |
Harpoon Therapeutics IncHARP | +118.10% | $10.55 | $23.01 | 2024-01-04 - 2024-03-08 | Buy |
Hartaj Singh Analyst Color
Get additional color on Hartaj Singh's coverage of popular stocks
Hartaj Singh's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Gilead Sciences IncGILD | 4 | Buy | $132.00 | +26.52% | Maintains | 2 months ago |
Astria Therapeutics IncATXS | 8 | Buy | $28.00 | +581.27% | Maintains | 5 months ago |
Regeneron Pharmaceuticals IncREGN | 6 | Buy | $1,000.00 | +78.10% | Maintains | 6 months ago |
United Therapeutics CorpUTHR | 5 | Buy | $600.00 | +111.08% | Maintains | 6 months ago |
Vertex Pharmaceuticals IncVRTX | 10 | Buy | $540.00 | +13.08% | Maintains | 6 months ago |
Spruce Biosciences IncSPRB | 5 | Buy | $3.00 | +2,379.34% | Maintains | 10 months ago |
Cellectis SaCLLS | 4 | Buy | $10.00 | +624.64% | Maintains | 10 months ago |
Moderna IncMRNA | 6 | Buy | $179.00 | +612.30% | Maintains | 10 months ago |
Biomea Fusion IncBMEA | 5 | Buy | $60.00 | +3,388.37% | Maintains | a year ago |
Viracta Therapeutics IncVIRX | 3 | Buy | $11.00 | +14,002.56% | Maintains | a year ago |
Sarepta Therapeutics IncSRPT | 5 | Buy | $180.00 | +225.91% | Upgrades | a year ago |
Gain Therapeutics IncGANX | 4 | Buy | $9.00 | +417.24% | Maintains | a year ago |
Inovio Pharmaceuticals IncINO | 3 | Buy | $40.00 | N/A | Maintains | a year ago |
Entrada Therapeutics IncTRDA | 1 | Buy | $22.00 | N/A | Initiates Coverage On | a year ago |
Harpoon Therapeutics IncHARP | 1 | Buy | $23.00 | N/A | Initiates Coverage On | a year ago |
Icosavax IncICVX | 3 | Buy | $25.00 | N/A | Reiterates | 2 years ago |
Opthea LtdOPT | 3 | Buy | $16.00 | N/A | Maintains | 2 years ago |
Eloxx Pharmaceuticals IncELOX | 3 | Buy | $55.00 | N/A | Maintains | 2 years ago |
Oncternal Therapeutics IncONCT | 2 | Buy | $180.00 | N/A | Maintains | 2 years ago |
Neubase Therapeutics IncNBSE | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Atyr Pharma IncATYR | 3 | Buy | $20.00 | N/A | Maintains | 4 years ago |
F Star Therapeutics IncFSTX | 1 | Buy | $30.00 | N/A | Initiates Coverage On | 4 years ago |
Alexion Pharmaceuticals IncALXN | 2 | Hold | N/A | N/A | Downgrades | 5 years ago |
Sellas Life Sciences Group IncSLS | 1 | Buy | $650.00 | N/A | Initiates Coverage On | 6 years ago |
Arqule IncARQL | 1 | Buy | $7.00 | N/A | Initiates Coverage On | 7 years ago |
Summit Therapeutics IncSMMT | 1 | Buy | $30.00 | N/A | Maintains | 7 years ago |
Imunon IncIMNN | 1 | Buy | $9.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.